title: New approaches for the identification of drug targets in protozoan parasites.
abstract: Antiparasitic chemotherapy is an important issue for drug development. Traditionally, novel compounds with antiprotozoan activities have been identified by screening of compound libraries in high-throughput systems. More recently developed approaches employ target-based drug design supported by genomics and proteomics of protozoan parasites. In this chapter, the drug targets in protozoan parasites are reviewed. The gene-expression machinery has been among the first targets for antiparasitic drugs and is still under investigation as a target for novel compounds. Other targets include cytoskeletal proteins, proteins involved in intracellular signaling, membranes, and enzymes participating in intermediary metabolism. In apicomplexan parasites, the apicoplast is a suitable target for established and novel drugs. Some drugs act on multiple subcellular targets. Drugs with nitro groups generate free radicals under anaerobic growth conditions, and drugs with peroxide groups generate radicals under aerobic growth conditions, both affecting multiple cellular pathways. Mefloquine and thiazolides are presented as examples for antiprotozoan compounds with multiple (side) effects. The classic approach of drug discovery employing high-throughput physiological screenings followed by identification of drug targets has yielded the mainstream of current antiprotozoal drugs. Target-based drug design supported by genomics and proteomics of protozoan parasites has not produced any antiparasitic drug so far. The reason for this is discussed and a synthesis of both methods is proposed.
authors: Institute of Parasitology, University of Berne, Berne, Switzerland. joachim.mueller@vetsuisse.unibe.ch
authors: Joachim
authors: J
authors: Müller
authors: Andrew
authors: A
authors: Hemphill
mesh_terms: D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology* / Q000627:therapeutic use*; D058990:Molecular Targeted Therapy / Q000379:methods*; D010271:Parasites / Q000166:cytology / Q000187:drug effects* / Q000648:ultrastructure; D011528:Protozoan Infections / Q000188:drug therapy* / Q000469:parasitology
chemical_list: D000981:Antiprotozoal Agents